CatalystPit

SLXNSilexion Therapeutics Corp

NASDAQ · Biological Products, (No Diagnostic Substances)
Last close $0.28 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
Market cap$1.54M
RECENT INSIDER TRADES
  • 2026-06-08 · Shirvan Mitchell (CSO and CDO) · OTHER
  • 2026-06-08 · Horenshtein Hadar Mirit (CFO and Secretary) · OTHER
  • 2026-06-08 · Hadar Ilan (Chairman and CEO) · OTHER
  • 2026-03-30 · Shirvan Mitchell (CSO and CDO) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders12
Shares held1,123,763
Value$57.79K
Percent of shares outstanding20.21%
As of quarter end2026-06-30
RECENT NEWS
  • Silexion Therapeutics doses first patient in Phase 2/3 trial of SIL204
  • Silexion Therapeutics exercises warrants for 3.2M shares at $0.2603
  • Silexion Therapeutics Reports Positive Preclinical Findings for SIL204
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Silexion Therapeutics Corp (SLXN) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit